CA1267617A - Article for immobilizing biologically active protein - Google Patents

Article for immobilizing biologically active protein

Info

Publication number
CA1267617A
CA1267617A CA000522429A CA522429A CA1267617A CA 1267617 A CA1267617 A CA 1267617A CA 000522429 A CA000522429 A CA 000522429A CA 522429 A CA522429 A CA 522429A CA 1267617 A CA1267617 A CA 1267617A
Authority
CA
Canada
Prior art keywords
article according
protein
treatment
layer
inorganic oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000522429A
Other languages
French (fr)
Inventor
Rosa Uy
Arlene J. Mencke
Carol E. Hendrickson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of CA1267617A publication Critical patent/CA1267617A/en
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124Hydrogen peroxide; Peroxy compounds
    • A61L12/126Hydrogen peroxide; Peroxy compounds neutralised with catalase or peroxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811Peptides or proteins is immobilized on, or in, an inorganic carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815Carrier is a synthetic polymer

Abstract

ABSTRACT

A composite article comprises in sequence a fibrous support which has been subjected to a surface treatment to provide binding sites thereon, a layer of a protein immobilizer compound, and a biologically active protein. The surface treatment comprises a gelled network of inorganic oxide particles or a plasma treatment.

Description

~ ~7 Ei~ ~

ARTICLE FOR IMMOBILIZING BIOLOGICALLY ACTIVE PROTEIN

Field of the Invention This invention relates to a composite article S comprising an immobilized biologically active protein.
In another aspect, a process for preparing the composite article of the invention is disclosed. The article can be - used in a method for disinfecting ~edical devices, particularly contact lenses.
Background of the Invention Soft contact lenses, such as those made from plastic gel materials, e.g., hydroxyethyl methacrylate (HEMA) or its analogues and ethylene glycol dimethacrylate (EGMA) or its analogues, are replacing traditional hard contact lenses as the lenses of choice for many people.
SoPt lenses are more comfortable to wear than the hard lenses, but they pose a more complex problem than the hard lenses when it comes to care and maintenance. Hard lenses 20 may be cleaned and disinfected relatively easily. Since they do not absorb appreciable amounts of water and aqueous solutions, the use of somewhat harsh cleaning and disinfecting agents is not generally a problem.
- Soft lenses, on the other hand, require greater 25 care in cleansing and storage. The solutions useful with hard lenses often are not compatible with soft lenses because the soft lenses tend to absorb or concentrate certain constituents of the formulation, which could result in damage to the lens or harm to the eye of the user.
Similarly, soft lenses are more vulnerable to microbial contamination than are hard lenses. The nutritive effect of body fluids, and the protective effect of nicks or imperfections in soft lenses, can serve to augment the growth of microbes.

While it is relatively easy to find antimicrobial agents active against such microbial contaminants, it is more difficult to find an antimicrobial agent that is compatible with soft contact lenses, and more difficult ye~
to find one that is non-irritating and safe for contact with the human eye.
Antimicrobial agents which are suitable for external contact or even for injection or ingestion are often unsuitable for use in eye care due to the 10 particularly sensitive nature of the tissues in the eye.
For example, they might be unsuitable because of direct toxicity to the eye, poor solubility in aqueous vehicles, eye irritation or ocular allergenic effects, absorption or binding by the contact lens, or chemical interaction with 15 the contact lens or even its plastic lens case.
An antimicrobial agent useful for ocular applications must not contrlbute to any of the above problems. In particular, it must satisfy two basic requirements, i.e. that it be non-irritating to the eye, 20 and that it be effective against a wide variety of microorganisms.
Hydrogen peroxide is a very effective antimicrobial agent which is currently used to disinfect contact lenses, including soft contact lenses. Although it 25 is potentially irritating to the eye if significant residues are contained on or in the contact lens, it is known that hydrogen peroxide can be removed by soaking a . disinfected le~s in a solution containing a catalyst such as platinum oxide which càtalyzes the decomposition of 30 hydrogen peroxide.
Solutions of the enzyme catalase have also been added to decompose hydrogen peroxide in solutions previously used to sterilize contact lenses. See, for example, European Patent application 82710055.3. However, 35 if introduced into a solution with a lens, catalase can bind to the lens, compounding the familiar protein deposit problem associated with the use of contact lenses.

~76~
-3- 60557~3120 It is known in the art that certain proteins can be immobilized on specific supports. U.S. Patent ~,092,645 describes the immobilization of enzymes on isocyanate end-capped polyurethane polymer foams, and catalase is one of a long list of enzymes listed and claimed.
U.S. Patent 3,282,702 describes certain classes of polymeric carriers which bind catalase for the purpose of providing articles for removing hydrogen peroxide from potable liquids.
U.S. Patent 4,210,722 describes a method of Lmmobilizing a protein such as an enzyme on a polar support in a variety of configurations which can be glass, ceramic, inorganic oxlde, etc.
comprising applying a layer of a polymer having repeating units containing a beta-hydroxyalkyleneamine moiety such as the dimethylamine adduct of epoxidized polybutadiene to a polar support and contacting the treated support with an aqueous solution of the protein. One of the enzymes exemplified in this patent is catalase.
Summar~ Oe the Invention ~riefly, the present invention provides a composition article comprising in sequence:
a) a fibrous support having a large surface area which has been subjected to a surface treatment to provide binding sites l~rO~ Icil n ~
thereon, said treatment comprising~l J

(1) a layer of inorganic oxide having a uniform thickness when dried in the range of 2 to 500 nm, or
(2) a radio frequency or microwave plasma treatment, .`' ~ ' , ~7~
-3a- G0557-3120 (b) a layer of a protein immobilizer compouncl, and (c) a biologically active protein.
In another aspect, a process for preparing composite ar~icles containing immobilized protein is disclosed.
Fibrous supports, such as woven and particularly nonwoven webs, because of their ease of handling and high surface area, provide d~sirable constructions upon which proteins such as enzymes can be immobilized. It has been found, however, that some of the ~ypical polymers used to make woven and nonwoven webs, such as polyalkylenes, do not irreversibly adsorb or bind the protein immobilizers known to the art. Immobilized proteins such as enzymes can ., ~

~7~

retain a substantial portion of their biological activity even though bound to a support.
Surprisingly, it has been found that certain polymers, including polyalkylenes, commonly used to make 5 nonwoven webs can be used as supports for protein immobiliæation if their surface is first subjected to a modification treatment capable of providing binding sites for a protein immobilizer compound. It has not previously been known to treat woven and nonwoven webs for the purpose 10 of providing binding sites for chemical additives to immobilize biologically active molecules.
It has not previously been known that it is possible to achieve disinfection with hydrogen peroxide while simultaneously decomposing excess hydrogen peroxide 15 by the use of the protein catalase immobilized upon a support. In particular, the use of catalase, immobilized upon a woven or nonwoven fibrous support coated with a layer of inorganic oxide or subjected to a plasma treatment, to decompose hydrogen peroxide has not been 20 known.
Hydrogen peroxide systems, which have been used to disinfect contact lenses, may be classified by the number of containers used during the disinfection process and by the number of steps required to complete the 25 disinfection process.
A two-container, two-step method involves separate, noncompeting reactions. In the first step lenses are put into a container containing an amount of hydrogen peroxide sufficient for disinfecting the lenses in a short 30 period of time (about 10 minutes). In the second step, as is known in the art, the lenses are then transferred to a second container which contains a saline solution and a disc of platinum. The platinum disc catalytically converts the hydrogen peroxide into molecular oxygen and water. The 35 lenses are soaked in the second container for four or more hours to remove the residual hydrogen peroxide from the lenses. Other systems which have been used to remove the hydrogen peroxide from the lenses can include either the - s -use of a solution of sodium bicarbonate or the enzyme catalase in solution. These systems may use one or two containers but always require two steps: first a soak in hydrogen peroxide and second a neutralization step.
S The two-step, two-container system is bulky, cumbersome and requires relatively large volumes of solutions. ~wo step, one-container systems are also bulky, cumberso~e and require more than one so:Lution. A problem arises when the wearer forgets the second step and does not neutralize the hydrogen peroxide in the lenses. The wearer then has lenses which are contaminated with hydrogen peroxide and are not suitable for use. It is, therefore, desirable to provide a system which uses only one container and one step to achieve the disinfection of the lenses and lS the neutralization of the hydrogen peroxide.
When a one-step system is used to disinfect contaet lenses there are two competing reactions which must be controlled to achieve disinfection as well as neutralizatlon. Qne reaction is the killing of the infectious organisms on the lenses by the hydrogen peroxideO The concentration of the hydrogen peroxida must remain at a high enough level for a period of time long enough to achieve disinfection. The second reaction is the conversion of residual hydrogen peroxide into water and 25 molecular oxygen or other compounds. ~he conversion reaction must be slow enough to allow killing of the microorganisms but fast enough to neutralize substantially all of the hydrogen peroxide in a period of time suitable or having the lenses ready for use (usually four to six 30 hours).
The present invention permits the use of a one-container, one-step system by controlling the amount of enzy~e present. The amount of immobilized enzyme put into the container can be controlled by selecting the 35 appropriate amount of composite article. A low amount of enzyme will cause a slow neutralization o~ hydrogen peroxide which will allow the disinfection to take place.

~76 ~ ~

If, on the other hand, a fast system for hydrogen peroxide disinfection is desired, a two-step system would be preferable: a large concentration of enzyme can be put into the container after the 10-minute disinfecting soak and the large amount of enzyme will neutralize the hydrogen peroxide very rapidly, reducing the total required time for disinfection. A very fast system is highly desirable for patients wearing extended wear lenses who do not wi6h to leave their lenses out of their eyes for the four- to six-hour period required by products currently available.
The activity of the enzyme in neutralizing hydrogen peroxide can also be attenuated by use of controlled release technology, as is known in the art. For example, the composite article of the invention may be coated with a slowly erodable polymer such as a celluloee derivative, polytN-vinyl pyrrolidone) or poly(vinyl alcohol). The erodable polymer coating on the surface prevents the enzyme from neutralizing the hydrogen peroxide and slowly dissolves in the hydrogen peroxide solution.
When the polymeric coating has dissolved into the solution, the enzyme neutralizes the hydrogen peroxide at a rate proportional to the amount of active enzyme present.
The medical devices which can be disinfected in conjunction with the composite article of the invention can be any article which is used in or applied to the human body and which must be free of significant amounts of hydrogen peroxide after disinfection. Such articles include devices used in the eye which may require regular disinfection such as contact lenses. Other articles suitable for disinfection include medical and dental instruments, surgical staples, and implants of various types. A method for disinfecting medical devices using the article of the invention is disclosed in assignee's copending patent application Canadian Serial No. 521,456, filed October 27, 1986.

7~
--7~

As used in this application:
"woven fibrous web" means a sheet or pad of interlaced strands of yarn;
"nonwoven fibrous web" means a sheet or pad of a random network of fibers;
"ceramic" means any inorganic nonmetallic material (includes metal and nonmetallic oxides) which requires the application of high temperatures at some stage in its manufacture but is not derived from a melt;
"ceramic-precursor" means a material capable of being converted to a ceramic by application of high temperature;
"sol" means a colloidal dispersion of a finely divided solid phase in a liquid medium;
"polar layer" means a layer the surface of which is wettable by water;
"continuous" means a layer with virtually no discontinuities or yaps therein;
"gelled network" means an aggregation of colloidal particles linked together to form a porous three-dimensional network;
"particle" means spherical, non spherical, and fibrillar particulate arrangements;
"primary particle size" means the average size of 25 unagglomerated single particles of inorganic metal oxide;
"porous" means the presence of voids created by the pac~ing of particles; the dried product preferably has an open porosity of between 25 and 70 percent;
"monolayer" means a thin layer approximately 10 30 to 250 angstroms thick, with the preferred thickness being in the range of 10 to 100 angstroms;
"mat" means unfused fibers;
"thermally bonded" means a mat of fibers that has been fused by heat at junction points (e.g., passed through 35 calendering rolls at 232C ~450~F)); and "embossing" means a mat of fibers thermally fused by imprinting a pattern on the mat.

7~

-~- 60557-3120 Detalled Descrip~ion_o _ he Invention The present invention provides a composite article comprising in se~uence:
a) a woven or nonwoven fibrous support hav~ng a large surface area which ha been subjected to a surface treatment to 1C~-provide binding sites thereon, said treatment comprising~
1) a layer of inorganic oxide having a uniform thickness when dried in the range of 2 to 500 nm which, preferably, is a layer of a porous ceramic-precursor gel, and 2) a radio fre~uency or microwave plasma treatment, b) a layer of a protein immohlllzer compound, and c) a biologically active protein, such as ~atalase.
For many uses it is desirable for a protein, once it has been immobilized on a support by means of a protein immobilizer, to be retained in its entirely or substantially in its entirety on the support so as to not contaminate another substance. It has been found that binding of a protein immobilizer to the support is enhanced when the support is provided with polar groups. Polar groups provide binding sltes whlch can then interact with the proteln immobillzer. Such blnding sites allow binding of the ; protein immobilizer to be maximized. The protein to be I immobilized can then be firmly attached to the support for its intended utility.
Woven and nonwoven web.s are useful as supports for the articles of the invention. Fibrous webs are desirable for use in the method of the invention because they provide large surfa~e areas for binding protein. Woven webs are alternatives to nonwoven webs for the purposes of the invention. A wide variety :~' 7~ t~

-8a- 60557-3120 of fiber diameters, e.g., 0.05 micrometers in to 50 micrometer diameter, preferably O.l to 20 micrometers, can be used as the support in ~he composite articles of the invent.ion. Any web thickness can be useful in specific applications, preferably 0.2 micrometer ~o 100 cm thick, most preferably 0.1 mm to 1 cm. In applications such as filtration, chromatography, or plasmaphoresis, web thicknesses of 50 and even 100 cm or more can be useful.

6 ~

Nonwoven fibrous webs are preferred in the practice of the invention. Nonwoven webs have several advantages over woven materials including high surface area, ease of manufacture, low material cost, and allowance for variation in fiber texture and fiber density.
The preferred materials useful to prepare nonwoven fibrous web compositions of the invention include polymers and copolymers of monomers which form fibrous webs. Suitable polymers include polyalkylenes such as 10 polyethylene and polypropylene, polyvinyl chloride, polyamides such as the various nylons, polystyrene, polyarylsulfones, polyvinyl alcohol, polyacrylates such as polymethyl methacrylate, polycarbonate, cellulosics such as cPllulose acetate butyrate, polyesters such as 15 poly(ethylene terephthalate), polyimides, and polyurethanes such as polyether polyurethanes, and combinations thereof.
Nonwoven webs may also be prepared from combinations o co-extruded polymers such as polyester and polyalkylenes.
Copolymers of the monomers which provide the 20 above-described polymers are also included within the scope of the invention. Nonwoven webs may also be combined webs which are an intimate blend of fine fibers and crimped staple fibers.
Fibrous webs of the invention can be prepared by 25 methods known in the art. Nonwoven form webs may be prepared by melt-blowing as is known to those skilled in the art and described in, for example, U.S. Patent No.
3,978,185 and in V.A. Wente et al. "Manufacture of Superfine Organic Fibers", Naval Research Lahoratories 30 Report No. 4364, Naval Research Laboratories, Washington, D.C. (U.S. Document No~ 111437). Alternative techniques such as solution-blowing can also be used as described, for example, in U.S. Patent No. 2,571,457. The method used to prepare the nonwoven material is not critical.

.

6~

Nonwoven webs can be embossed or thermally bonded, as is known in the art, to give integrity to the web. Pillowing of nonwovens can be useful and is described in detail in United States Patent Nos. 4,042,740 and
4,103,058. The nonwovens of these patents are useful in the present invention. Woven fibrous webs include any type of patterned or knitted fabric or pad.
In one embodiment, the fibrous support can be coated on one or more surfaces with a layer of an inorganic 10 oxide capable of providing binding sites to the support surface. Such materials are wettable by water and include metal oxides, glasses, ceramic precursors, and clays.
Silaceous materials such as sand, glass and quartz are generally suitable. Inorganic compounds such as oxides and 15 barium ferrite are also considered suitable. Preferred materials are inorganic oxides which form gelled networks.
Most preferably the polar layer is a continuous, porous ceramic-precursor gel layer consisting of spherical particles preerably of 20 to 600 angstroms and most 20 preferably of about 50 angstroms in diameter. These gels - are preferred because they are found to bond readily to nonwoven webs. The amount of gel used will generally be about 0.06 to 0.15 grams per gram of nonwoven web.
The layer of inorganic oxide is substantially 25 uniform in thickness and is substantially permanently adhered to the support, i.e. has a 180 peelback value of at least about 150 g/cm, preferably at least about 500 g/cm (as measured on polyester (PET) film). The dried coating is preferably from about 2 to 500 nm thick. Such 30 coatings provide good adhesion. When the coating thickness is too great, the coating has reduced adhesion and flexibility and may flake off or form powder under mechanical stress.
In another embodiment, a plasma treatment 35 utilizing an activated gas such as air, oxygen, carbon dioxide, argon, helium, nitrous oxide, water vapor, and the like, and combinations thereof, can be utilized as an ~ _ _ _ _, _ _ _ _ . _ _ _ _ . _ . . .. . ... . ..

- alternative to a layer of inorganic oxide material, to provide a water-wettable or polar surface on the support.
These treatments are alternatives to use of a layer of polar material coated on the support.
Protein immobilizers useful in the method of the invention are any of the known polymers which adhere readily to polar supports and provide lmmobilization of proteins, such as enzymes, while preferably retaining substantially all of the biological activity of the 10 protein.
Included among the suitable protein immobilizers and/or coupling agents are polymers having repeating units containing a beta-hydroxyalkyleneamine moiety, silane-functional compounds such as gamma-aminopropyltriethoxy-15 silane and silane-treated polycarbodiimide polymers of U.S.
Patent 4,118,536.
It is presently preferred to use polymers such as those described in U.S. Patent 4,210,722. The polymers described as use~ul in that invention are generally useful 20 in the present invention. A particularly preferred type of polymer described in the above patent is N,N-dialkylamine adducts of epoxidized polybutadiene such as the N,N-dimethylamine adduct of epoxidized polybutadiene. Although this reference discloses only 25 ~ater-soluble protein immobilizers, the present invention includes within its scope both water-soluble and organic solvent-soluble (e.g., toluene) protein immobilizers.
Especially preferred polymers for practicing the invention are formed from amine adducts of epoxidized 30 poly-cis-1,4-butadiene, epoxidized styrene/cis-1,4-butadiene, and polyglycidyl methacrylate wherein the amine can be a primary or secondary amine such as dimethylamine, diethylamine, morpholine, piperidine, or n-propylamine, as described in U.S. Patent No. 4,210,722.
The ~-hydroxyalkyleneamine-containing polymers have molecular weights ranging from lO00 to several million. However, the preferred molecular weight is in the range of 10,000 to 250,000. As the molecular weight is increased above about 250,000, the aminated polymers create preparative problems.
Enzymes immobilized by, for example, ~-hydroxyalkyleneamine-coated fibrous supports as described herein, are useful in enzymatic chemical processing in the conventional manner. Examples thereof include the use of glucose isomerase in the conversion of glucose to fructose, 10 and the use of lactase in the removal of lactose during the isolation of proteins from cheese whey. Further examples of enzymes which can be strongly attached, for example, to the ~-hydroxyalkyleneamine polymers include urease, glucose oxidase, invertase, catalase, peroxidase, papain, lipase, 15 cellulase, dextranase, amylase, ribonuclease, carboxypeptidase and urokinase.
Immunochemicals such as antigens and antibodies may be conveniently attached to supports according to the inventlon and used in a conventional manner.
Examples of immunologically-active proteins which may be immobilized according to the invention include gamma globulins, haptoglobin, a1-antitrypsin inhibitor, serum albumin transferrin, complement and a-globulins.
The process of the invention in one embodiment 25 comprises coating woven or nonwoven webs with a polar compound from a solution or sol containing inorganic oxide particles, the particles preferably having an average primary particle size less than about 200 angstroms (A), more preferably less than about 70 A. The solution 30 preferably contains 0.2 to 15, preferably 0.5 to 6, weight percent of the particles. At particle concentrations above 15 weight percent, the resulting coating may have reduced uniformity in thickness and exhibit reduced adhesion to the support surface. At concentrations below 0.2 weight 35 percent, process inefficiencies result due to the large amount of liquid which must be removed.

It is preferred to use sols of inorganic oxides, particularly sols o~ ceramic-precursor materials as the polar compound used to coat the ibrous supportsO
Inorganic oxides particularly suitable for use in the present invention include colloidal silica particles, boehmite (alpha-Al2O3-H2O), tin oxide (SnO2), antimony oxide (Sb2O5), zirconium oxide (ZrO2), and alumina-coated silica a~ well as other inorganic oxides of Groups III and IV of the Periodic Table and mixtures thereof. The selection of the inorganic oxide depends upon its ability to adhere to the support and provide adequate binding for the protein immobilizer compound.
Examples of commercially available inorganic metal oxides include colloidal silica sols (NalcoTM 2326 15 and NalcoTM 1034A, Nalco Chemical Co., Oak ~rook, I~), disper6able alumina boehmite (DispuralTM and PuralTM, Condea Petrochemie GmbH, and Catapal SBTM, Vista Chemical Co.), alumina 501 (Nalco IS~-614TM, Nalco Chemical Co.), antimony oxide sol (Nalco ISJ-611TM, Nalco Chemical Co.), 20 and alumina-coated silica sol (Nalco ISJ-613TM, Nalco Chemical Company).
The term "solution" as used herein includes dispersions or suspensions of finely divided particles of ultramicroscopic size in a liquid medium. The solutions 25 used in the practice of this invention are clear to milky in appearance.
The coating solution may also optionally contain a surfactant to improve wettability of the solution on the support, but inclusion of an excessive amount of surfactant 30 may reduce the adhesion of the coating to the support.
Examples o~ suitable surfactants preferably include nonionic surfactants such as trimethyl nonyl polyethylene glycol ether (Tergitol TMN-6TM, Union Carbide Corp.) and octylphenoxy polyethoxy ethanol (Triton x-100TM, Rohm and 35 Haas Co.). Generally, the surfactant can be used in amounts of up to about 0.5 weight percent of the solution.

;7~

The coating solution may optionally contain a polymeric binder to aid in adhering the coating-to the support. Useful polymeric binders include polyvinyl alcohol, polyvinyl acetate, polyesters, polyamides,
5 polyvinyl pyrrolidone, copolyesters, copolymers of acrylic acld and/or ~ethacrylic acid, and copolymers of styrene.
The coating solution can contain up to about 20 weight percent of the polymeric binder based on the weight of the inorganic metal oxide particles. Useful amounts of 10 polymeric binder are generally in the range of 1 to 15 weight percent.
Addition of various adjuvants, such as slip agents and processing oils, to the support material can be useful but may reduce the adhesion of the coating to the 15 support.
Coating may be carried out by standard coating techniques such as bar coating, roll coating, curtain coating, spraying and dipping, or other techniques known to those in the art. The support may be treated prior to 20 coating to obtain a uniform coating using techniques such as corona disoharge, flame treatment, and electron beam.
Generally, no pretreatment is required.
The thickness of the applied wet coating solution is dependent on the concentration of inurganic oxide 25 particles in the coating solution and the desired thickneæs of the dried coating. The thickness of the wet coating solution is preferably such that the resulting dried coating thickness is from about 70 to 250 nm thick, more preferably about 100 to 200 nm thick.
After soaking a nonwoven web in the coating , solution containing inorganic oxide particles the web is either dried at a moderately low temperature, generally less than about 200C, preferably 80 to 120C, or at room temperature, provided the drying time is sufficient to 35 permit the coating to dry completely to provide good bonding of the oxides to the nonwoven webs. The drying temperature should be less than that at which the support degrades.

. 1, 3L ô~

An alternative process for modifying the surface of woven or nonwoven webs is a plasma treatmentO ~ plasma is generated by electrical discharge of the gas utilized between two flat electrodes, at a reduced pressure. Direct current (D.C.) or alternating current (A.C.) radiofrequencies or microwave plasmas can be useful, preferably at 10 to 125 kiloherz. Gas pressures of 10 mtorr to 10 torr can be used, preferably 0.5 to 2.0 torrO
Power ranges preferably are 10 to 400 watts or power 10 densities in the range of 0.05 to 2.25 w/cm2.
Nonwoven or woven fibrous webs positioned between the two electrodes can be exposed to a plasma treatment for 1 second to 30 minutes, preferably 10 to 60 seconds.
Depending on the gas used, a plasma treatment 15 provides the surface of the support with reactive, polar groups including hydroxy, ester, acid, carbonate, amine, peroxide, and hydroperoxide groups. These groups are a source of binding sites for the protein immobilizer compound.
The protein immobilizer coating is provided by deposition of any of the protein immobilizer polymers described above, preferably in a monolayer. The polymer is deposited onto the polar support from a dilute solution.
Preferably the solution is an aqueous one. Generally, 25 solutions containing 0.03 to 0.5 percent polymer (w/w) are used.
For example, the ~-hydroxyalkyleneamine polymer can be deposited as a monolayer on the polarized surface of the support by immersing the support in a dilute aqueous 30 solution of the polymer for 30 seconds to 24 hours, followed by a water wash. The support may be dried and stored or used immediately to contact an aqueous solution of the protein to be immobilized.
Deposition of the protein on the composite 35 article, comprising a fibrous support which has been surface treated as described above and protein immobilizer compound, is preferably accomplished by immersion of the . _ .. _ .. .. . _ _ . _ . . _ _ . _ _ .. .

;jr~ ~7 ~
-~6-composite in the protein solution which preferably is a buffered aqueous solution. The optimum concentration of the protein solution will vary depending on the protein to be immobilized. Generally, protein solutions in the range 5 of 0.01 to lO0 mg/mL will be used. Following an equilibration period of a few seconds to 24 hours, the composite is removed from the protein and washed with water and/or buffer until unbound protein is removed. The resulting composite can then be dried in air and/or over a 10 desiccant. In some cases, lyophilization can be used.
objects and advantages of this invention are further illustrated by the following examples, but the particular materials and amounts thereof recited in these examples, as well as other conditions and details, should 15 not be construed to unduly limit this invention.
The phosphate buffer used throughout the Example~, unless otherwise speci~ied, was 0.01 M potassium dihydrogen phosphate, pH having been adjusted to 7.25 with lN aqueous potassium hydroxide.
The catalase used throughout~the Examples is commercially available catalase with activity (according ts the manufacturer, Sigma Chemical Co.) of 40,000 ~nternational Units per milligram. However the activity was measured by a standard assay (described by ~eers and 25 Sizer, J. Biol. Chem. 195, 133 (1952~) wherein one unit of enzyme decomposed one micromole of hydrogen peroxide per minute at 15C at pH 7, to be 20,500 IU per milligram unless otherwise specified. All percents are by weight unless otherwise specified.
Example 1 Polypropylene blown microfiber (BMF) was placed in a plasma treatment chamber that was equipped with two 23 x 33 cm (9 x 13 inO) substantially parallel aluminum 35 electrodes. The material to be treated was placed on the non-driven electrode and the system evacuated to 10 millitorr. The system was then backfilled with O.S torr CO2 as measured with a Vacuum General manometer monomer and a plasma ignited with a PlasmalocTM generator (ENI, IncO) with A.C. power at 25 KHz and at 200 watts. The plasma treatment was run for 0.5 min. After treatment the sample 5 was brought to atmospheric pressure.
The trial was repeated using air, at 1~0 torr pressure, as the gas in the plasma treatment chamber.
~ ads were cut from the treated BMF and were weighed and soaked 6 hours at room temperature in 0.05%
DIMA solution. The pads were rinsed, drained, and soaked 16 hours at 4C in 0.1 mg catalase/ml in phosphate buffer.
The measured free catalase activity was 48,000 units~mg.
The pads were soaked and rinsed until no ~ree catalase was detected in the soaking solution.
The pads were soaked in 10 mL of 3~ ~22 solution and absorbance monitored at 240 nm as a function of time.
Tho data are shown in TABLE I below.

TABLE I
Absorbance at 240 nm Plasma gas >15 sec. 5 min. 15 min. 30 min. 60 min.
C2 >4 0 2.51 0.15 0.01 0.01 air >4.0 3.30 0.65 0.19 0.01 The data show that a plasma treatment can produce binding sites for protein immobilizers on 3MF pads, and the pads are useful in the construction of the present invention.
Example 2 Pads of nonwoven web of both an embossed and mat form of copolyester of 80/20 polyethylene terephthalate and polyethylene isophthalate, nylon 66, and thermally bonded 35 polyethylene terephthalate (1.0 g each) were dipped in an amine stabilized sol of silicon dioxide (Nalco 2326, Nalco Chemical Co., Oak srook, IL) containing 1.5% silicon dioxide in ethanol, then the pads were dried at 60C for about 15 minutes. The pads ~see TABLE I below~ were cut into pieces weighing 0.1 to 0.3 g, then soaked for six hours in 20 mL of 0.06~ aqueous solution of the - 5 dimethylamine adduct of epoxidized polybutadiene (DIMA).
The pads were drained, then rinsed with distilled water.
The pads were soaked in 10 mL of an aqueous phosphate-buffered sclution of 1 mg per mL of catalase for sixteen hours at 4C and at about 20C for 1.5 hours. The pads 10 were soaked in buffer, drained and rinsed with distilled water until no catalase activity could be detected in the washings. A nonwoven polypropylene pad was prepared similarly, but the soaking time in DIMA solution was 16 hours and in catalase solution 24 hours. All of the 15 drained pads were soaked in 10 mL of 0.2~ hydrogen peroxide solution and the absorbance of the solution was measured initially and at intervals specified in TABLE II. The concentration of hydrogen peroxide in the second container of a two-container system was assumed to be about 0.2% when 20 the volume of solution in the second container was 10 mL.

7~ ~ ;i TABL~ II
Absorbance at 240 Dm Pad (weight in g)sec.min. mirl.min. min. min.
A.embossed copoly- 2.11 1. 74 0.76 0.04 0.01 --ester (0.24 g) B.embossed copoly- 2.08 1. 57 0.56 0.05 0.01 --eseer (0.24 g) ~ 10 c.nylon 66*('0.14 g~ 0.82 0.62 0.05 -- 0.03 --si~ D.ther~ally bonded1.72 0.92 0.21 0.07 0.02 -_ PET (0.14 g) E.PET mat 1.83 1.80 0.97 0.28 0.14 0.02 (0.13 g) 15 F.copolyester mat 1.74 .18 0.69 0.15 0.11 0.02 (0.14 g) G.copolyester mat 1.97 1.45 0.61 0.10 0.09 --(O.lZ g) H.polypropylene 2. 47 -- 0.77 0.54 0.47 --(0-3 g) The data of TAsLE II show that absorbance decreased from a maximum of 2. 5 to a minimum range of 0.01 to 0.50 in 30 minutes. These values Gorrespond to a 25 decrease in hydrogen pero~ide concentration from about 0.15% to less than 0.001~.
These data indicate the article of the invention is efficacious in removing hydrogen peroxide to a negligible concentration when used in a two-container 30 system.
The soaked pads were then resoaked with 10 mL of 3% hydrogen peroxide solution and the absorbance of the solution at 240 nm was measured at various time intervals.
~he data are shown in TABLE III below.

~20-TABLE III
Abs~bance at 240 n~

~0 5 Pad sec. min. min. min. min. ~in.
Ao embossed copolyester 3.12 0.05 0.05 -- -- --(0024 g) B. nylon 66 0.45 0005 0.05 -- -- --~0.14 g) C.thermally bonded PET 3.10 0.120.110.12 -- 0.12 (0.14 g3 D.copolyester mat 3.152.99 3.02 -- 3.17 --(0.13 g) E.copolyester mat 3.050.24 0.10 0.07 -- --(0.12 g) F. polypropylene 4.0 2.17 0.070.06 -- --(0.3 g) The data of TABLE III show that the articles used 20 bound sufficient catalase to decompose 3~ hydrogen peroxide and therefore that the article of the invention was efficacious in removing hydrogen peroxide to a negligible concentration when a one-container system was used.

25 Example 3 The copolyester pad used in Example 2E, TABLE
III, was placed in a lO mL sample of 3% hydrogen peroxide in 0.01 M phosphate buffer, at pH 9.0, and the absorbance of the solution was measured at a wavelength of 240 30 nanometers at time intervals as shown in TABLE5 IV below.
The pH of the solution was 10.0 after 90 min. and 8.7 after 1~ hours.
The nylon pad of Example 2B and the copolyester pad of Example 2A were placed in 10 mL samples of 3~
35 hydrogen peroxide in 0.01 M phosphate buffer, at pH 4.7, and the absorbance of the solution was measured at time intervals as shown in TAB~E IV below. The pH of the ,~"

-solution containing the nylon pad was 6.2 and the solution containing the copolyester pad was 5 5 8, both measured after 90 minutes.
The pads were rinsed with phosphate buffer, pH
7.2, then drained and resoaked in 10 mL of 3% hydrogen peroxide in phosphate buffer, pH 7.4, and the absorbance at 240 nm was measured at time intervals as shown in TABLE IVo The p~ of the solutions containing the nylon and copolyester mats were 7.4 and 7.2, respectively, after 10 10 minutes of reaction.

TABLE IV
Absorbance at 240 nm 15 Pad 45 sec. 5 min. 15 min. 30 min. 60 min.
A. copolyester mat pH 9.0 3.15 0.19 0.17 0.16 0.14 7.4 3.15 3.07 3.09 3.07 B. embossed polyester 20pH 4.7 3.14 0.07 0.11 0.11 0.09 7.4 3.14 1.4 0.22 0.05 C. nylon mat pH 4.7 3.06 0.16 0.14 0~12 0.11 7.4 3.04 0.38 0.02 0.02 The data of TABLE IV show that the articleg of the invention were efficacious under both acidic and basic conditions and remained useful even after cycling in an acidic solution of hydrogen peroxide.
Example 4 A polypropylene pad weighing about 0.2 g containing catalase bonded to DIMA, prepared as described in Example 2, was refrigerated at 4C for one hour and then 35 immersed in 10 mL of 3% hydrogen peroxide solution also at 4C. The absorbances measured at less than~10 sec, 15 min, and 2-1/2 hours were greater than 4, 0.09 and 0.04, .

respectively, indicating greater than 0.2%, 0.005% and 0.004% concentrations of hydrogen peroxide remaining, respectively.
This data of this Example show that the method of S the invention works at relatively cold temperatures suitable for the storage of catalase.

Example 5 An embossed polypropyl~ne pad prepared according to the method of Example 2 was stored for two days at 4C
in a desiccator. The pad was then soaked in 10 mL of buffer for 15 minutes at room temperature; the solution was decanted and the pad was immersed in 10 mL of 3% hydrogen peroxide solution and the absorbance was measured using the 15 method of Example 1. For the pad stored dry, the average absorbance initially was greater than 4 and decreased to 0.009 at 60 minutes, corresponding to hydrogen peroxide concantrations of greater than 0.2% and less than 0.004%, respectively. The data showed that the article of the 20 invention continued to function by decomposing hydrogen peroxide after being dried and rehydrated.

Example 6 Pads of various nonwoven webs as described in 25 Example 2 weighing 0.1 to 0.2 g were dipped in an a~ine stabilized sol of silicon dioxide (Nalco 2326, Nalco Chemical Company, Oak Brook, IL) containing ~.5% silicon dioxide in ethanol, then the pads were drained and dried at 60C for about 15 minutes. The dry pads were soaked for 24 30 hours, each pad in 10 mL of 0.5% of silane-treated polycarbodiimide in toluene at about ~0C. The pads were then rinsed with 20 mL of toluene, air dried in a fume hood ~or 16 hours and cured by heaking for 15 minutes at 60C.
The pads were each soaked in 3 mL of a 10 mg/mL solution of 35 catalase for 4 hours at about 20C, rinsed with distilled water and soaked in phosphate buffer (pH 7) for about 16 hours. The pads were rinsed again with distilled water and 7~
-23~

soaked in buffer for another 16 hours. No catalase activity was detected in the soaking solution. Each of the pads was then immersed in 10 m1 of 0.2% hydrogen peroxide solution and the absorbance of the solution was measured at S various time intervals using the method described in Example 1. The data are shown in Table v.

TABL~ V
Absor~ance at 240 n~
~0 P sec. min. min. min. min. min.
A. embossed copolyester 2.22 1.89 1.37 0.10 0.62 0.35 (0.19 g) 15 B. embossed copolyester 2.36 2.07 1.55 1.04 0.72 0.60 (0.16 g) C. nylon 66 2.04 2.03 1.50 1.23 0.94 0.82 (0.07 ~) D. thermally bondedPET 2.31 1.90 1.29 0.76 0.77 0.29 t0.08 g) E. eopolyester mat 1.98 1.76 1.38 1.04 0.67 0.67 (0.11 g) F. copolyester mat 2.04 1.60 0.98 0.80 (0.09 g) These data show that the absorbance decreased to less than 1.0 in 60 minutes which corresponds to a hydrogen peroxide concentration of less than 0.05%. The data also show that coupling agents other than DIMA are useful in the 30 construction of the invention.

Pads of nonwoven webs of polypropylene and nylon 66 were soaked for 24 hours in about 25 mL of a 0.06 35 solution of the dimethylamine adduct of epoxidized polybutadiene at about 20C. The pads were rinsed with distilled water. The pads were then soaked in 25 mL of a ~ 7~

solution of catalase (1 mg per mL in 0.01 M phosphate bu~fer pH 7.2) for 3 hours at 4C and 2.5 hours at about 20C. The pads were alternately soaked in buffer, drained and rinsed with distilled water overnight until no catalase activity could be detected in the washings.
A companion set of pads was prepared as controls in a similar manner but a ceramic-precursor gel layer was applied by dipping the nonwoven pads in 1.5% amine stabilized sol of silicon dioxide (Nal,o 2326) at a ratio of about 0.1 g silicon oxide to 1.25 g nonwoven fibers.
The nylon and polypropylene pads were dried at about 60QC
for fifteen minutes. A 10 mL portion of 3~ hydrogen peroxide in 0.01 M phosphate buffer, pH 7.2, was added to each pad and the decomposition of hydrogen peroxide was 15 monitored by recording the absorbance of the solution at 240 nm at time intervals up to at least thirty minutes.
The data are shown in TA~LE VI (A-D). The nylon pad~ were soaked for about 65 hours with 2 bu~fer changes, then drained and resoaked in 10 mL of 3% H202. The 20 decomposition was monitored as stated ahove. See TA~LE VI
(E and F).

TABLe VI
Absorba~ce at 240 nm Pads (all with DIMA) ~eight sec. min. min. min. min.
A. polypropylene + SiO2 0.10 > 4 > 4 1.97 0.91 0.24 B. polypropylene, no SiO20.18 > 4 ~ 4 > 4 > 4 > 4 30 C. nylon 66 + SiO2 0.10 > 4 0.82 0.22 0.10 0.04 D. nylon 66, no SiO2 0.12 ~ 4 > 4 E. nylon 66 + SiO2 0.10 - 3.20 2.81 1.80 0.09 F. nylon 66, no SiO2 0.12 - 3 .173 .19 -- 3.15 The data of TA~LE VI show that a polypropylene pad without a gel coating showed no detectable enzymatic activity within thirty minutes, and the nylon pad without a 'q~J
- -25~

gel coating showed reduced enzymatic activity within thirty minutes.

Example 8 Embossed copolyester ~80% polyethylene terephthalate, 20~ polyethylene isophthalate) nonwoven pads were prepared as in Example 7 with no DrMA coatingO A
companion copolyester pad was prepared with DIMA as a cont~ol. The addition and decomposition of 3% hydrogen 10 peroxide solution was effected as disclosed in Example 7.
The data are shown in TAsLE VII.

TABL~ VII
Absorbance a~ 240 nm Pads with SiO sec. min. min. min. min.
2 _ _ embossed copolyester, with DIMA (3.5 x 3.5 cm) ~ 4 3.20 3.07 0.78 0.45 embossed copolyester, no DIMA (3.5 x 3.5 cm) > 4 3.26 3.37 3.15 3.13 The data of TA~LE VII show a significant increase in catalase activity bound to the fibrous web when the DIMA
coating is used.
Example 9 A cellulose pad (No. 2 Whatman filter paper) and woven nylon were coated with silicon dioxide, DIMA, and catalase as described in Example 7.
A pad of alumina-boria-silica 3:1:2 ceramic fiber (NextelTM 312, 3M, St. Paul, MN) was coated with DIMA and catalase as described above in Example 7. A 10 mL aliquot of 3% hydrogen peroxide solution was added to each pad and the absorbance of the solution at 240 nm was monitored.
35 The absorbance data are shown in TABLE VIII below.

ot~

TABLB VII
Absorbance at ~40 nm Weight 1 5 15 30 (in ~) min. min.minO min.
cellulos~ 0.65 3.1~ 0.22Q. 2a 0.22 woven Nylon 0.64 >4 0.570.71 0.17 Nextel 312 1.36 >4 1.03 -- 0.11 The data of TABLE VIII for absorbance show detectable bound catalase when evaluated in 10 mL of 3~
hydrogen peroxide demonstrating that supports other than nonwovens can be used in this construction.

lS Example 10 Catalase was bound to a nonwoven polyethylene terephthalate pad which was provided with DIMA and gel coatings as described ln Example 2. Pads were sterilized with ethylene oxide at 29C and degassed at 4C for several days.
Ten polyvinylpyrrolidone/HEMA lenses (SoftconTM
American Optical, 55% water content soft contact lenses) were inoculated with sixty five million Pseudomonas aeruginosa (American Type Culture Collection, ATCC, #27853) colony forming units (cfu).
Two lenses were cleaned with sausch and LombTM
Daily CleanerTM and microoganism~ were eluted with 5~
Tween-80TM saline solution and plated on tryptic soy agar.
~bout eight thousand cfu's of the Pseudomonas aeruginosa were present on the lenses before hydrogen peroxide disinfection.
Eight of the ten lenses were cleaned with Bausch and Lomb Daily Cleaner and rinsed with sterile saline and ; placed in lens holders.
In a two-container, two-step system, a lens was inserted into each of two containers containing 10 mL of 3%
hydrogen peroxide, in 0.01 M phosphate buffer, p~ 7.2, for 10 minutes, removed and reinserted into containers con-~i7~

taining 10 mL of phosphate buffer. A 0.13 g pad of poly-ester witb i~mobilized catalase as prepared in ~xa~ple 2 was inserted with the lens which was soaked for four hoursO
In a one container, one-step system, a lens was inserted into each of two containers containing 10 mL of 3 hydrogen peroxide in phosphate buffer with 0.15 g pads containing catalase and soaked for 4 hours.
Two lenses were disinfected and neutralized as recommended by the manufactuxer in two SepticonTM Catalytic Disinfection Systems. This system requires soaking lenses in about 10 mL of LenseptTM (3~ H2O2) solution for ten minutes, removal, and reinsertion in a second container with about 10 mL of Sensitive EyesTM saline solution (Bausch & Lomb) and a platinum coated disc for four hours.
Two lenses were placed in 10 mL of sterile saline for four hours.
The eight lenses were removed from the disinfection containers, then placed in 10 m~ tryptic soy broth and incubated at 35C for 6 days. The final soaking 20 solutions were transferred to 100 mL of broth and incubated for 6 days at 35C. At the end of the 6-day incubation, ? containers of broth were scored for the presence of visible turbidity in the solutions. Visible turbidity in the incubated broth indicated lack of disinfection (+). The 25 results are shown in Table IX below.

TABLE I~

~E~ System Lens Soak solution 1 2-step, 2-container catalase 2 2-step, 2-container catalase - -3 1-step, 1-container catalase 4 1-step, 1-container catalase Septicon - -~
35 6 Septicon 7 saline only 8 saline only +

, . .. . . . . .. .. .

In TABLE IX the data show that one lens without hydrogen peroxide disinfection was not disinfected. The saline soaks from both of these lenses showed microbial growth. The Sensitive Eyes soaking solution from one of the Septicon systems also was not disinfectedO The catalase one-step and two-step systems both resulted in disinfected lenses and the soak solutions show no microbia}
growthO
The data of Table IX show the method of the invention can be used in a one-step, one-container system, and also in a two-step, two-container system.

Various modifications and alterations of this invention will become apparent to those skilled in the art 15 without departing from the scope and spirit of this invention, and it should be understood that this invention i5 not to be unduly limited to the lllustrative e~bodiments set ~orth herein.

Claims (26)

The embodiments of the invention in which an exclusive property of privilege is claimed are defined as follows:
1. A composite article comprising in sequence:
a) a fibrous support having a large surface area which has been subjected to a surface treatment to provide binding sites thereon, said treatment comprising providing:
(1) a layer of inorganic oxide having a uniform thickness when dried in the range of 2 to 500 nm, or (2) a radiofrequency or microwave plasma treatment, b) a layer of a protein immobilizer compound, and c) a biologically active protein.
2. The article according to Claim 1 wherein said support is woven or nonwoven.
3. The article according to Claim 2 wherein said support is nonwoven.
4. The article according to Claim 2 wherein said support is polyalkylene, polyvinyl chloride, polyamide, polyvinyl alcohol, polystyrene, polyarylsulfone, polyester, polycarbonate, polyacrylate, cellulosic, polyurethane, or combinations thereof.
5. The article according to Claim 1 wherein said surface treatment comprises a layer of inorganic oxide, glass, or clay.
6. The article according to Claim 1 wherein said surface treatment comprises a gelled network of inorganic oxide particles or a plasma treatment.
7. The article according to Claim 6 wherein said surface treatment is a gelled network of inorganic oxide particles.
8. The article according to Claim 6 wherein said surface treatment is a ceramic-precursor gel.
9. The article according to Claim 6 wherein said surface treatment is a plasma treatment.
10. The article according to Claim 9 wherein said plasma treatment utilizes a gas selected from the group consisting of air, oxygen, carbon dioxide, argon, helium, nitrous oxide,or water vapor.
11. The article according to Claim 10 wherein said gas is air or carbon dioxide.
12. The article according to Claim 1 wherein said protein immobilizer compound is a beta-hydroxyalkyleneamine-containing polymer, a silane-functional compound, or a silane-treated polycarbodiimide polymer.
13. The article according to Claim 1 wherein said protein immobilizer compound is an amine adduct of epoxidized poly-cis-1,4-butadiene, epoxidized styrene/cis-1,4-butadiene, or polyglycidyl methacrylate.
14. The article according to Claim 13 wherein said amine is dimethylamine, diethylamine, morpholine, piperidine, or n-propylamine.
15. The article according to Claim 1 wherein said protein is an enzyme, an immunochemical, or an immunologically-active protein.
16. The article according to Claim 15 wherein said enzyme is urease, glucose oxidase, invertase, peroxidase, catalase, papain, lipase, cellulase, dextranase, amylase, ribonuclease, carboxypeptidase or urokinase.
17. The article according to Claim 15 wherein said enzyme is catalase.
18. A composite article comprising in sequence:
(a) a fibrous support having a large surface area which has been subject to a surface treatment to provide binding sites thereon, said treatment comprising providing:
(1) a layer of inorganic oxide having a uniform thickness when dried in the range of 2 to 500 nm, or (2) a radiofrequency or microwave plasma treatment, and (b) a layer of a protein immobilizer compound.
19. The article according to Claim 18 wherein said surface treatment comprises a layer of inorganic oxide, glass, clay, or ceramic precursor.
20. The article according to Claim 18 wherein said surface treatment comprises a gelled network of inorganic oxide particles or a plasma treatment.
21. The article according to Claim 18 wherein said surface treatment is a gelled network of inorganic oxide particles.
22. The article according to Claim 20 wherein said plasma treatment utilizes air, oxygen, carbon dioxide, argon, helium, nitrous oxide, or water vapor.
23. The article according to Claim 22 wherein said plasma 31a 60557-3120 treatment utilizes air or carbon dioxide.
24. A composite article comprising in sequence:
(a) a nonwoven fibrous support having a large surface area which has been subject to a surface treatment to provide binding sites thereon, said treatment comprising providing, (b) a layer comprising a gelled network of silica particles having a uniform thickness when dried in the range of 2 to 500 nm, (c) a layer of a beta-hydroxyalkyleneamine-containing polymer, and (d) a layer of biologically active catalase.
25. A method for providing a composite article comprising the steps:
a) surface-treating a woven or nonwoven fibrous support having a large surface area to provide binding sites for a protein immobilizer compound, said treatment comprising providing:
(1) a layer of inorganic oxide having a uniform thickness when dried in the range of 2 to 500 nm, or (2) a radiofrequency or microwave plasma treatment, b) coating said treated surface with a layer of a protein immobilizer compound, and c) attaching a biologically-active protein to said protein immobilizer compound.
26. The method according to Claim 25 wherein said surface treatment is a gelled network of inorganic oxide particles or a plasma treatment.
CA000522429A 1985-11-08 1986-11-07 Article for immobilizing biologically active protein Expired - Fee Related CA1267617A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US796,274 1985-11-08
US06/796,274 US4757014A (en) 1985-11-08 1985-11-08 Immobilization of biologically active protein on a polymeric fibrous support

Publications (1)

Publication Number Publication Date
CA1267617A true CA1267617A (en) 1990-04-10

Family

ID=25167776

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000522429A Expired - Fee Related CA1267617A (en) 1985-11-08 1986-11-07 Article for immobilizing biologically active protein

Country Status (2)

Country Link
US (2) US4757014A (en)
CA (1) CA1267617A (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794002A (en) * 1985-11-01 1988-12-27 Monsanto Company Modified polymeric surfaces and process for preparing same
US4757014A (en) * 1985-11-08 1988-07-12 Minnesota Mining And Manufacturing Company Immobilization of biologically active protein on a polymeric fibrous support
US4829001A (en) * 1985-11-08 1989-05-09 Minnesota Mining And Manufacturing Company Enzymatic neutralization of hydrogen peroxide
GB8701706D0 (en) * 1987-01-27 1987-03-04 Ici Plc Immobilisation of enzymes
DE3824258C2 (en) * 1987-07-23 1999-04-29 Bst Bio Sensor Tech Gmbh Modified enzyme membrane for enzyme electrodes with high selectivity and process for their application
WO1990001167A1 (en) * 1988-07-19 1990-02-08 E.I. Du Pont De Nemours And Company Porous support system for the immobilization of immunoassay components and assays performed therewith
US5071909A (en) * 1989-07-26 1991-12-10 Millipore Corporation Immobilization of proteins and peptides on insoluble supports
US5204062A (en) * 1989-09-05 1993-04-20 Surgicot Incorporated Bowie-dick test device
AU9158491A (en) * 1990-12-19 1992-07-22 Allergan, Inc. Compositions and methods for contact lens disinfecting
US5993935A (en) * 1991-10-11 1999-11-30 3M Innovative Properties Company Covalently reactive particles incorporated in a continous porous matrix
US5344701A (en) * 1992-06-09 1994-09-06 Minnesota Mining And Manufacturing Company Porous supports having azlactone-functional surfaces
US5292514A (en) * 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US6036918A (en) * 1993-03-17 2000-03-14 Enviro Medical Systems, Inc. Vapor sterilization
NO931809L (en) * 1993-05-19 1994-11-21 Norsk Hydro As hemophilia
EP0713420B1 (en) * 1993-08-13 1997-08-06 Minnesota Mining And Manufacturing Company Cartridge filter with insoluble enzyme particulates contained thereon
US5561045A (en) * 1994-01-04 1996-10-01 Intracel Corporation Detection reagent, article, and immunoassay method
US5549891A (en) * 1994-04-05 1996-08-27 Allergan Method for disinfecting contact lens with catalase compositions
US5476665A (en) * 1994-04-13 1995-12-19 Minnesota Mining And Manufacturing Company Azlactone functional particles incorporated in a membrane formed by solvent phase inversion
AU2732495A (en) * 1994-06-13 1996-01-05 Novo Nordisk A/S Contact lenses with immobilized proteins for disinfecting and delivering oxygen to the eyes
JP3708567B2 (en) * 1994-07-20 2005-10-19 日清紡績株式会社 Method for immobilizing biologically active substances
EP0815310B1 (en) * 1995-03-14 2003-08-27 Kimberly-Clark Worldwide, Inc. Wettable article
US5637497A (en) * 1995-06-28 1997-06-10 Alcon Laboratories, Inc. Apparatus and method for cleaning and disinfecting contact lenses
DE19742980A1 (en) * 1997-09-29 1999-04-01 Espe Dental Ag Dental compositions based on ROMP oligomers or polymers
US6951682B1 (en) * 1998-12-01 2005-10-04 Syntrix Biochip, Inc. Porous coatings bearing ligand arrays and use thereof
US7011940B1 (en) 1999-04-14 2006-03-14 Medical Discovery Partners Llc Quality control for cytochemical assays
US6808908B2 (en) 2001-05-30 2004-10-26 Porex Technologies Corporation Functionalized porous substrate for binding chemical and biological moieties
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
TWI308214B (en) * 2002-09-10 2009-04-01 Univ Nat Central Method of forming a biochip and application thereof
US20050130226A1 (en) * 2003-09-26 2005-06-16 The University Of Cincinnati Fully integrated protein lab-on-a-chip with smart microfluidics for spot array generation
US20050130177A1 (en) 2003-12-12 2005-06-16 3M Innovative Properties Company Variable valve apparatus and methods
US7727710B2 (en) * 2003-12-24 2010-06-01 3M Innovative Properties Company Materials, methods, and kits for reducing nonspecific binding of molecules to a surface
US7939249B2 (en) 2003-12-24 2011-05-10 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
US20070055013A1 (en) * 2005-02-21 2007-03-08 Noriho Kamiya Substrate and method of immobilizing protein
US20070141723A1 (en) * 2005-12-16 2007-06-21 Sompuram Seshi A Immunohistochemistry staining controls
US20070161308A1 (en) * 2006-01-12 2007-07-12 North Carolina State University Atmospheric pressure plasma-aided antimicrobial finishes of textiles
US8105682B2 (en) * 2006-09-01 2012-01-31 The Regents Of The University Of California Thermoplastic polymer microfibers, nanofibers and composites
DE102010027936A1 (en) 2010-04-19 2011-10-20 Institut für Biochemie Ernst-Moritz-Arndt-Universität Greifswald Immobilization of enzyme using plasmas
CN103748058B (en) 2011-09-06 2016-08-31 维塔蔡恩法布里克H劳特尔两合公司 The method preparing medical ceramic implantation body
US10478518B2 (en) * 2016-03-02 2019-11-19 Better Vision Solutions LLC Method for disinfecting contact lenses

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282702A (en) * 1963-07-16 1966-11-01 Union Carbide Corp Process for removing hydrogen peroxide from liquids
US3715278A (en) * 1970-02-11 1973-02-06 Monsanto Co Enzyme-polymer product attached to surface of siliceous materials thereof
US3928143A (en) * 1972-02-23 1975-12-23 Robert W Coughlin Method of carrying out enzyme-catalyzed reactions
US4115198A (en) * 1974-02-11 1978-09-19 Coughlin Robert W Method of immobilization of biologically active organic substances including enzymes
US4098645A (en) * 1976-02-24 1978-07-04 W. R. Grace & Co. Immobilization of proteins with polyurethane polymers
US4038485A (en) * 1976-03-18 1977-07-26 Miles Laboratories, Inc. Test composition, device, and method
CA1099844A (en) * 1976-10-08 1981-04-21 Minnesota Mining And Manufacturing Company Silane-terminated polycarbodiimide
US4210722A (en) * 1977-11-14 1980-07-01 Minnesota Mining And Manufacturing Company Protein immobilizer
EP0003923B1 (en) * 1978-02-16 1982-10-20 Rhone-Poulenc Specialites Chimiques Support-enzyme complexes and method for preparing them
US4473550A (en) * 1981-01-16 1984-09-25 Rosenbaum Robert S Bactericidal compositions and methods
US4748992A (en) * 1981-12-21 1988-06-07 Ciba Vision Care Corporation Contact lens disinfection
ATE30511T1 (en) * 1981-12-21 1987-11-15 Titmus Eurocon Kontaktlinsen PROCEDURE FOR DISINFECTING AND CLEANING CONTACT LENSES.
US4448884A (en) * 1982-03-03 1984-05-15 Kms Fusion, Inc. Glass-surface microcarrier for growth of cell cultures
US4588586A (en) * 1983-01-03 1986-05-13 Kessler Jack H Method for disinfecting a contact lens
DE3410400A1 (en) * 1984-03-21 1985-09-26 Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg CONTACT LENS CARE KIT AND METHOD FOR MAINTAINING CONTACT LENSES AND A CLEANING DEVICE THEREFOR
US4564532A (en) * 1985-01-07 1986-01-14 Kms Fusion, Inc. Glass-surface microcarrier for anchorage-dependent cell cultivation
GB8515079D0 (en) * 1985-06-14 1985-07-17 Kellway Pharma Contact lens cleaning & disinfection
DE3532433A1 (en) * 1985-09-11 1987-03-26 Iip Inst Fuer Ind Pharmazie Fo Contact-lens care set
EP0209071B2 (en) * 1985-07-10 1998-07-15 Novartis AG Cleaning set for contact lenses
US4757014A (en) * 1985-11-08 1988-07-12 Minnesota Mining And Manufacturing Company Immobilization of biologically active protein on a polymeric fibrous support

Also Published As

Publication number Publication date
US4855234A (en) 1989-08-08
US4757014A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
CA1267617A (en) Article for immobilizing biologically active protein
EP0223479B1 (en) Article and method for enzymatic neutralization of hydrogen peroxide
US4829001A (en) Enzymatic neutralization of hydrogen peroxide
US10709807B2 (en) Porous devices, kits, and methods for debridement
US4004979A (en) Preparation of active proteins cross-linked to inactive proteins
Van Pelt et al. Adhesion of Streptococcus sanguis CH3 to polymers with different surface free energies
CA2097062C (en) Hydrogen peroxide destroying compositions and methods of making and using same
JP3963954B2 (en) Air purification filter
US6503761B1 (en) Selective removal of contaminants from a surface using articles having magnets
EP0119233B1 (en) Means for removing microorganisms from tissue
US20040050254A1 (en) Air purifying filter using modified enzymes
MY116007A (en) Absorbent sheet, process for producing the same and absorbent article
WO1998051711A1 (en) Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore
Busscher et al. Kinetics of adhesion of the oral bacterium Streptococcus sanguis CH3 to polymers with different surface free energies
Miura et al. The characteristics of anticoagulation by covalently immobilized heparin
FI922825A0 (en) Process for the preparation of a pharmaceutical preparation for controlling pathogenic microorganisms
SE513375C2 (en) Absorbent articles having a material laminate comprising a liquid-permeable surface layer and a liquid-permeable liquid transfer layer
US5746972A (en) Compositions and methods for disinfecting and cleaning contact lenses
US5185415A (en) Adsorptive resin for microorganisms
CA1326209C (en) Glass microbeads having bacteriostatic properties and process for manufacturing such microbeads
Wyrick et al. Growth of streptococcal protoplasts and L-colonies on membrane filters
MXPA02003912A (en) Selective removal of contaminants from a surface using magnets.
WO1995026755A1 (en) Catalase compositions for destroying hydrogen peroxide and methods for using same
Brown Cytochemical electron microscopic localization of esterase activity in Lactobacillus casei
JPH10168722A (en) Antimicrobial wet-type nonwoven fabric

Legal Events

Date Code Title Description
MKLA Lapsed